|
|
Article: A new way to deliver psychiatric meds: drugs for ADHD and major depression now can be delivered with skin patches.(TREATMENT ADVANCES)
- Article from:
- Behavioral Healthcare
- Article date:
- August 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 Vendome Group LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Psychiatric pharmacotherapy traditionally has involved pills, liquids, and shots. Prescribers now can add skin patches to that list.
Earlier this year the FDA approved the transdermal delivery (i.e., through the skin) of two psychiatric drugs:
* EMSAM was approved for treatment of major depressive disorder in adults. EMSAM delivers selegiline, a monoamine oxidase inhibitor (MAOI), transdermally (figure 1).
* Daytrana was approved for treatment of ADHD. Daytrana is a once-a-day transdermal treatment using methylphenidate, a central nervous system stimulant (figure 2).
While these are the first approved transdermal applications of ...